CD8A and neoplasm: B16-SIY tumor cells were subcutaneously injected to WT C57BL/6 mice and tumor antigen-specific CD8+ T cells were detected via Flow cytometry by SIY-specific tetramer staining, 6 days after the initial Erb-sumIL2 treatment (Supplementary Fig. 5d; Fig. 3d).